SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-18-009407
Filing Date
2018-02-14
Accepted
2018-02-14 07:52:36
Documents
1
Group Members
BROOKSIDE CAPITAL INVESTORS II, L.P.BROOKSIDE CAPITAL TRADING FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a18-5675_2sc13ga.htm SC 13G/A 148084
  Complete submission text file 0001104659-18-009407.txt   149970
Mailing Address C/O BAIN CAPITAL PUBLIC EQUITY, LP 200 CLARENDON STREET BOSTON MA 02116
Business Address C/O BAIN CAPITAL PUBLIC EQUITY, LP 200 CLARENDON STREET BOSTON MA 02116 617-516-2000
Bain Capital Public Equity Management, LLC (Filed by) CIK: 0001156175 (see all company filings)

IRS No.: 043517087 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102 (206) 682-0645
Immune Design Corp. (Subject) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88256 | Film No.: 18607166
SIC: 2834 Pharmaceutical Preparations